Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
https://www.polarityte.com/
It may just be they haven't bothered to take down the site yet, but the company sure doesn't appear to be gone just yet. Still trading. AI is hot and AI/Regeneration sounds like a good future prospect ... We'll see ;
Yep, this may be one of those "hard to believe" stonks.
IDK, but I got a feeling. Holding 3k shares @.065 ... lotto play. Could go Large!
Polarityte Inc., PTEIQ, changed to Regenetp Inc., RGTPQ
https://otce.finra.org/otce/dailyList?viewType=Symbol%2FName%20Changes
PTE changed to PTEIQ, bankruptcy. Delisted from the Nasdaq to the OTC:
https://otce.finra.org/otce/dailyList?viewType=Additions
steady vol.,now mid day pushing,getting found and ppl dding,watch for demand to start the chase
$1.70pps book value,74% increase in profitability,low debt,institutions should be eyeing this soon
planned acquisition $1.25 per share,completed?,would explain 470Xs buying vol.
6M float,(1.22Xs rotation today)7M o/s!,withdrew offering,big move coming?
$1.7M traded,470Xs ave buying vol,ZERO BORROW,NOT OPTIONABLE,120K sh. short
$1.7M traded,470Xs ave buying vol,ZERO BORROW,NOT OPTIONABLE,120K sh. short
What again?
Off all time lows, seems like a good entry for me.
Lots of crap going on, but an FDA approval, and some clinicals going on could be worth a purchase here.
Short interest is decreasing but there could be more covering to come. Other stocks beaten down like L Tee C H hit 0.86 also and caught a rally... maybe something will come here for its float.
PolarityTE Reports First Quarter 2022 Financial Results and Provides Business Update
https://finance.yahoo.com/news/polarityte-reports-first-quarter-2022-113000577.html
Today’s news are fantastic.
PTE is reborn. Looking forward to full FDA approval.
You were right on that. I got in and out quick thankfully
Hmmm gap has to fill first
Boom time! $PTE
Sell the spike
Trading 101
(Posting error)
And even MORE so, a 'Dump-A-Thon' in the OPEN Market as well, right at the Opening bell!!! Talk about an early morning SUCKERS'-BATE-GAPPER about to jump-off!!
NEWS
PolarityTE Announces FDA Regenerative Medicine Advanced Therapy Designation Granted to SkinTE®
SALT LAKE CITY, May 13, 2022 /PRNewswire/ -- PolarityTE, Inc. (Nasdaq: PTE) today announced that the U.S. Food and Drug Administration (FDA) granted a Regenerative Medicine Advanced Therapy (RMAT) designation to SkinTE under the Company's open IND.
Established under the 21st Century Cures Act, RMAT designation is a dedicated program designed to expedite the drug development and review processes for promising regenerative medicine products, including human cellular and tissue-based therapies. A regenerative medicine therapy is eligible for RMAT designation if it is intended to treat, modify, reverse, or cure a serious or life-threatening disease or condition, and preliminary clinical evidence indicates that the drug or therapy has the potential to address unmet medical needs for such disease or condition. Similar to Breakthrough Therapy designation, RMAT designation provides the benefits of intensive FDA guidance on efficient drug development, including the ability for early interactions with the FDA to discuss potential ways to support accelerated approval and satisfy post-approval requirements, potential priority review of the biologics license application (BLA), and other opportunities to expedite development and review.
Richard Hague, Chief Executive Officer, commented "FDA granting our request for an RMAT designation for SkinTE validates not only the strength of the preliminary clinical evidence we have developed to date but also demonstrates the seriousness of the conditions that we seek to treat and the substantial nature of the unmet needs among the patient populations that we aim to serve. We were pleased to receive this news from the FDA nearly two weeks in advance of the 60-day time period that the Agency has to make such decisions. The Agency has offered—and we look forward to capitalizing upon—a multidisciplinary, comprehensive discussion between PolarityTE and the FDA regarding the SkinTE development program, including planned clinical trials and plans for expediting the manufacturing development strategy. We are eager to work closely with the Agency to identify potential means to accelerate our development program and help bring a much-needed potential new treatment to patients suffering from substantial unmet medical needs."
Knew nothing about this company whatsoever until the run up yesterday and got in pre-market as an in and out play. I'm still in with around 300K shares after doing a little research and seeing the massive volume yesterday. A lot of eyes got on this stock yesterday and I am just 1 example. In doing my research, I totally get the capital issues the company is having and understand future issues.
However, the stock has a couple very good news opportunities and more importantly have an extremely viable product with significant positive and reportable results. See link as an example of just one (1) of many successful case studies: ncbi.nlm.nih.gov/pmc/articl... . This is definitely a buyout opportunity and value is there. I'm going to stay and watch this for a moment, but I see this particular stock as a more of a value/risk holding in favor of the substantial value.
#DDAmanda Chart on: $PTE up 83% since Alert:
You can scan for these before they run.
What the Fact (Factor) Column is:
The Factor is a proprietary indicator used for scanning in #DDAmanda.
It's defined as Today's $Traded divided by the average daily $Traded (20 day avg).
SO, if a stock has say a 10 Factor that day, it means she traded 10 Times the $ she normally trades.
That's significant, and many times indicates that a run in the stock is coming.
hmmmmmmmmmmmm
Message in reply to:
This will move with good news. Rumors should move it too
silky knows:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=167445284
This will move with good news. Rumors should move it too
Big volume lately and it's moving up. Should get some feedback from FDA soon. The Investor Presentation, that had those great pictures is no longer on the website, FDA must have made them remove it.
Most of the small-cap bios I watch are getting trashed, following the IBB, seems to be a sector thing. The shorts just seen to all do whatever the sector is doing. This whole sector has been a mess, for years.
It is starting to act better, maybe this it.
They think they have enough cash to fund the company thru Q3 of 2022. I didn't hear any surprises there, they have really chopped expenses.
Added 4K shares to my stash, sure like the way it's trading.
I've not had the time to go thru all that and try to figure it out. The last trial met primary and secondary end-points, so I reckon the fda could OK it, at any time.
Any thoughts on the upcoming IND/EUA/BLA process?
Yup, the big gamble. I used to sell covered calls on ARRY. Worked out great for years and then I lost $100K one day, when the company got bought by PFE. Still made a lot of money, as I had a lot more of the stock.
Trading is acting better and with very low volume - tells me the attitude has changed.
GL! Welcome to the dice game in the back-alley.
If you see any cops, yell Policia! and start running...
Bought 100 of them this morning - Fido gets $25 for the transaction.
Might buy some of those myself, I'm expecting a huge move, long before Nov.
Thx. Big would be nice, but just a pop so there's some time value left in the options would be nice. My average is ~.085, so I'm looking for a .20 bid to start letting them go. Just lottery tickets at this point...
Sure hope you hit big, I own a lot of the stock and think it's a big winner.
Followers
|
24
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
223
|
Created
|
09/19/18
|
Type
|
Free
|
Moderators |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |